From Clinical Runs to Commercial Supply: Scaling AAV Production Without $3 Million Per Dose Costs
- Evaluating how early-stage manufacturing strategies for novel delivery platforms can be adapted for large-scale production without compromising quality or cost
- Exploring how automation, AI-driven design, modular unit operations, and raw material standardization can streamline process transfer and support scalable, reproducible manufacturing across diverse modalities
- Assessing technology transfer and process intensification approaches to enable costefficient, high-yield production for clinical and commercial supply